Rapid decrease of anti-β-glucan antibody as an indicator for early diagnosis of carinii pneumonitis and deep mycotic infections following immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis

Clinical Rheumatology

Volumn 28, Issue 5, 2009, Pages 565-571

  Yoshida, Masaharu ^a   Ishibashi, Ken Ichi ^b   Hida, Shunsuke ^b   Yoshikawa, Noriko ^a   Nakabayashi, Iwao ^a   Akashi, Masakazu ^a   Watanabe, Taeko ^a   Tomiyasu, Tomohiro ^a   Ohno, Naohito ^b  

^a TOKYO MEDICAL UNIVERSITY HACHIOJI MEDICAL CENTER   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

ANCA associated vasculitis; Anti glucan antibody; Carinii pneumonitis; Deep mycotic infection; Immunosuppressive treatment; Opportunistic infection

Indexed keywords

ANTIBODY; BETA GLUCAN; BETA GLUCAN ANTIBODY; C REACTIVE PROTEIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISONE; UNCLASSIFIED DRUG;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ANTIBODY TITER; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG DOSE INCREASE; DRUG MEGADOSE; EARLY DIAGNOSIS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PNEUMOCYSTIS PNEUMONIA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REMISSION; RHEUMATOID ARTHRITIS; THROMBOCYTOPENIA;

AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIFUNGAL AGENTS; ASPERGILLUS; BETA-GLUCANS; CANDIDA ALBICANS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOSES; PNEUMONIA; REMISSION INDUCTION; REPRODUCIBILITY OF RESULTS; VASCULITIS;

EID: 64449086290     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1096-0     Document Type: Article

References (20)

1. Savage CO (2001) ANCA-associated renal vasculitis. Kidney Int 60:1614-1627
2. Yoshida M, Yoshikawa N, Yano T, et al (2001) Analysis of risk factor in anti-neutrophil cytoplasmic antibody associated vasculitis with injection. Report by the research committee of the Ministry of Health and Welfare of Japan. Ministry of Health and Welfare of Japan, Tokyo 229-237
3. Jarrousse B, Guillevin L, Bindi P, Hachulla E, Leclerc P, Gilson B et al (1993) Increased risk of Pneumocystis carinii pneumonia in patients with Wegener's granulomatosis. Clin Exp Rheumatol 11:615-621
4. Brakhage AA, Schmidt A, Jahn B, eds. (1999) Aspergillus fumigatus. Biology, clinical aspects and molecular approaches to pathogenicity. Tokyo: Karger, S.
5. Ohno N, Uchiyama M, Tsuzuki A, Tokunaka K, Miura NN, Adachi Y et al (1999) Solubilization of the yeast cell-wall β-(1→3)-D -glucan by sodium hypochlorite oxidation and dimethyl sulfoxide extraction. Carbohydr Res 316:161-172
6. Uchiyama M, Ohno N, Miura NN, Adachi Y, Tamura H, Tanaka S, Yodomae T (2000) Solubilized cell wall beta-glucan, CSBG, is an epitope of Candida immune mice. Biol Pharm Bull 23:672-676
7. Masuzawa S, Yoshida M, Ishibashi K-I, Saito N, Akashi M, Yoshikawa N et al (2003) Solubilized Candida cell wall β-glugan, CSBG, is an epitope of natural human antibody. Drug Dev Res 58:179-189
8. Wang G, Csenok E, Groot K, Gross WL (1997) Comparison of eight commercial kits for quantitation of antineutrophil cytoplasmic antibodies (ANCA). J Immunol Methods 208:203-211
9. Tamura H, Arimoto Y, Tanaka S, Yoshida M, Obayashi T, Kawai T (1994) Automated kinetic assay for endotoxin and (1→3)-β-D-glucan in human blood. Clin Chim Acta 226:109-112
10. Swanink CM, Meis JF, Rijs AJ, Donnelly JP, Verweij PE (1997) Specificity of a sandwitch enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 35:257-260
11. Stegeman CA, Cohen Tervaert JW, de Jong PE, Kallenberg CGM (1996) Trimethoprim-Sulfamethoxazole (Co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Eng J Med 335:16-20
12. Yoshida M (2002) Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis: From molecular analysis to bedside. Intern Med 41:47-49
13. Palsson R, Choi HK, Niles JL (2002) Opportunistic infections preceded by a rapid fall in antineutrophil cytoplasmic antibody (ANCA) titer in patients with ANCA associated vasculitis. J Rheumatol 29:505-510
14. Kondori N, Ededo L, Baltzer M (2003) Candida albicans cell wall antigens for serological diagnosis of candidemia. Med Mycol 41:21-30
15. Kondori N, Ededo L, Baltzer M (2004) Circulating β(1,3) glucan and immunoglobulin G subclass antibodies to Candida albicans cell wall antigens in patiens with systemic candidiasis. Clin Diagn Lab Immunol 11:344-350
16. Ishibashi K, Miura N, Adachi Y, Tamura H, Tanaka S, Ohno N (2004) The solubilization and biological activities of Aspergillus beta-(1-3) D glucan. FEMS Immunol Med Microbiol 42:155-166
17. Ishibashi K, Yoshida M, Nakabayashi I, Shinohaha H, Miura N, Adachi Y, Ohno N (2005) Role of antiβ-glucans antibody in host defence against fungi. FEMS Immunol Med Microbiol 44:99-109
18. Jenntte JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitis proposal of an international Consensus conference. Arthritis Rheuma 37:187-192
19. Reddy S, Wanchu A, Cuputa V, Bambery S (2006) Profile of opportunistic infections among patients on immunosuppressive medication. APLAR J Rheumatol 9:269-274
20. Persat F, Ranque S, Derouin F, Michel-Nguyen A et al (2008) Contribution of the (1-3)-β-d-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 46:1009-1013